DSY: Prosthesis, Vascular Graft, Of 6mm And Greater Diameter
What it covers
A vascular graft prosthesis is an implanted device intended to repair, replace, or bypass sections of native or artificial vessels, excluding coronary or cerebral vasculature, and to provide vascular access. It is commonly constructed of materials such as polyethylene terephthalate and polytetrafluoroethylene, and it may be coated with a biological coating, such as albumin or collagen, or a synthetic coating, such as silicone. The graft structure itself is not made of materials of animal origin, including human umbilical cords.
The identification in 21 CFR 870.3450, vascular graft prosthesis. FDA gives DSY no definition of its own, so the regulation’s describes it.
FDA flags DSY devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K252445 | Fusion Bioline Vascular Graft | Maquet Cardiovascular, LLC | Apr 27, 2026 | Traditional |
| K252277 | Spiral Laminar Flow Vascular Arteriovenous Graft (AV0645) | Vascular Flow Technologies Limited | Oct 20, 2025 | Traditional |
| K241550 | Gelweave Vascular Prostheses | Vascutek, Ltd. | Feb 27, 2025 | Traditional |
| K241070 | Gelsoft Plus Vascular Prostheses | Vascutek, Ltd. | Nov 15, 2024 | Traditional |
| K231972 | Advanta VXT Vascular Graft, Flixene Vascular Graft | Atrium Medical Corporation | Mar 28, 2024 | Traditional |
| K240083 | GORE® PROPATEN® Vascular Graft | W. L. Gore & Associates, Inc. | Mar 1, 2024 | Traditional |
| K233783 | exGraft ePTFE Vascular Grafts, exGraft Carbon ePTFE Vascular Grafts | Peca Labs, Inc. | Jan 17, 2024 | Traditional |
| K232312 | GORE® PROPATEN® Vascular Graft | W. L. Gore & Associates, Inc. | Jan 9, 2024 | Traditional |
| K233551 | GORE® ACUSEAL Vascular Graft | W. L. Gore & Associates, Inc. | Dec 19, 2023 | Traditional |
| K231505 | GORE® ACUSEAL Vascular Graft | W. L. Gore & Associates, Inc. | Jun 23, 2023 | Special |
Clearances by year
34 DSY 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 266 |
| 2025 | 2 | 181 |
| 2024 | 5 | 160 |
| 2023 | 2 | 38 |
| 2022 | 2 | 154 |
| 2021 | 2 | 179 |
| 2020 | 1 | 105 |
| 2019 | 1 | 117 |
| 2018 | 1 | 131 |
| 2017 | 3 | 269 |
| 2016 | 1 | 69 |
| 2015 | 1 | 77 |
| 2014 | 2 | 71 |
| 2013 | 5 | 69 |
| 2012 | 4 | 30 |
| 2011 | 1 | 79 |
Who submits
15 applicants cleared a DSY device since 2011. 71% of the clearances went to applicants in United States, then United Kingdom (26%) and France (3%). By type: Traditional 74% and Special 26%.
| Applicant | Clearances since 2011 |
|---|---|
| Vascutek, Ltd. | 5 |
| W. L. Gore & Associates, Inc. | 5 |
| Peca Labs | 4 |
| Maquet Cardiovascular, LLC | 3 |
| Merit Medical Systems, Inc. | 3 |
| Vascular Flow Technologies, Ltd. | 3 |
| Atrium Medical Corporation | 2 |
| Hemosphere, Inc. | 2 |
How FDA classifies it
Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance Document for Vascular Prostheses 510(k) Submissions.”
From 21 CFR 870.3450. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 870.3450 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DSY clearances declared.
Ask about DSY
Questions about DSY
What is FDA product code DSY?
Product code DSY, “Prosthesis, Vascular Graft, Of 6mm And Greater Diameter” in FDA's classification database, is a Class II device type under 21 CFR 870.3450 (vascular graft prosthesis), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 188 clearances under DSY, 34 of them since 2011.
How many 510(k) clearances are there under DSY?
FDA’s 510(k) database listed 188 clearances under DSY as of Oct 29, 2026, 34 of them decided since 2011; the most recent decision was Apr 27, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DSY 510(k)?
For the 4 DSY clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 238 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DSY clearances?
Since 2011: Vascutek, Ltd. (5), W. L. Gore & Associates, Inc. (5), Peca Labs (4), Maquet Cardiovascular, LLC (3) and Merit Medical Systems, Inc. (3). 15 applicants have cleared a DSY device in that time.